# GK5

## Overview
The GK5 gene encodes the enzyme glycerol kinase 5, which is a member of the kinase family involved in lipid metabolism. This enzyme is pivotal in the conversion of glycerol to glycerol 3-phosphate, a critical step in the biosynthesis of triglycerides and phospholipids, thereby playing a significant role in energy storage and lipid droplet formation within cells (Yan2021Exposure). Glycerol kinase 5 is primarily active in the cytoplasm and is implicated in various cellular processes, including energy homeostasis, cell proliferation, apoptosis, and mitochondrial function. The gene's expression and regulation have been linked to cancer-related conditions, such as glioblastoma and non-small cell lung cancer, where it influences tumor suppression and drug resistance mechanisms (YU2015MicroRNA135b; Zhou2019Glycerol). Understanding the function and regulation of GK5 is crucial for elucidating its role in cellular metabolism and its potential as a therapeutic target.

## Function
Glycerol kinase 5 (GK5) is an enzyme that plays a crucial role in lipid metabolism by catalyzing the conversion of glycerol to glycerol 3-phosphate, a key step in the synthesis of triglycerides and phospholipids. This process is essential for lipid droplet formation and energy storage within cells (Yan2021Exposure). GK5 is primarily active in the cytoplasm, where it contributes to energy homeostasis and cellular signaling pathways. Its activity is particularly significant in the context of environmental stress, such as exposure to particulate matter and cigarette smoke, where it helps in the synthesis of lipid droplets, potentially serving as a protective mechanism against lipotoxicity (Yan2021Exposure).

In addition to its role in lipid metabolism, GK5 is involved in the regulation of cell proliferation, apoptosis, and mitochondrial function. It has been implicated in the resistance mechanisms of cancer cells to certain treatments, such as gefitinib, by modulating signaling pathways that affect cell survival and drug resistance (Zhou2019Glycerol). These functions highlight the importance of GK5 in maintaining cellular integrity and responding to metabolic and environmental challenges.

## Clinical Significance
Alterations in the expression of the GK5 gene have been implicated in various cancer-related conditions. In glioblastoma, a type of aggressive brain cancer, GK5 functions as a tumor suppressor gene. Its expression is significantly lower in glioblastoma tissues compared to healthy tissues, and this reduction is more pronounced in higher-grade tumors. The downregulation of GK5 in glioblastoma is mediated by microRNA-135b (miR-135b), which is upregulated in these tumors. The overexpression of miR-135b leads to decreased GK5 mRNA and protein levels, contributing to the oncogenic activity in glioblastoma by inhibiting GK5 expression (YU2015MicroRNA135b).

In non-small cell lung cancer (NSCLC), GK5 is associated with resistance to gefitinib, a drug used in cancer treatment. The expression of GK5 is upregulated in gefitinib-resistant lung adenocarcinoma cells. Silencing GK5 in these cells induces mitochondrial damage, caspase activation, cell cycle arrest, and apoptosis, suggesting that GK5 confers drug resistance by inhibiting apoptosis and cell cycle arrest. This resistance is mediated through the SREBP1/SCD1 signaling pathway, highlighting GK5 as a potential therapeutic target for overcoming gefitinib resistance in NSCLC (Zhou2019Glycerol).


## References


[1. (YU2015MicroRNA135b) YONG YU, JIAN-HUA ZHANG, and BAO-ZHONG ZHANG. Microrna-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression. Molecular Medicine Reports, 12(2):2721–2726, April 2015. URL: http://dx.doi.org/10.3892/mmr.2015.3708, doi:10.3892/mmr.2015.3708. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2015.3708)

[2. (Yan2021Exposure) Mengnan Yan, Yuanyuan Wu, Wenjun Peng, Cuiping Fu, Sergio Giunta, Meijia Chang, Ge Zhang, Maosen Dou, Shijin Xia, Huayin Li, Jian Zhou, and Yao Shen. Exposure to particulate matter 2.5 and cigarette smoke induces the synthesis of lipid droplets by glycerol kinase 5. Clinical and Experimental Pharmacology and Physiology, 48(4):498–507, January 2021. URL: http://dx.doi.org/10.1111/1440-1681.13463, doi:10.1111/1440-1681.13463. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/1440-1681.13463)

[3. (Zhou2019Glycerol) Jian Zhou, Guimei Qu, Ge Zhang, Zuoren Wu, Jing Liu, Dawei Yang, Jing Li, Meijia Chang, Hengshan Zeng, Jie Hu, Tao Fang, Yuanlin Song, and Chunxue Bai. Glycerol kinase 5 confers gefitinib resistance through srebp1/scd1 signaling pathway. Journal of Experimental &amp; Clinical Cancer Research, February 2019. URL: http://dx.doi.org/10.1186/s13046-019-1057-7, doi:10.1186/s13046-019-1057-7. This article has 28 citations.](https://doi.org/10.1186/s13046-019-1057-7)